Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel Tarning

Showing results (141-150 of 248) with videos related to

Pageof 25
Sort By:
Antimicrobial Agents and Chemotherapy|October 1, 2014
Open-label crossover study of primaquine and dihydroartemisinin-piperaquine pharmacokinetics in healthy adult thai subjectsBorimas Hanboonkunupakarn, Elizabeth A Ashley, Podjanee Jittamala, et al.
Malaria Journal|May 21, 2024
Population pharmacokinetics of primaquine and its metabolites in African malesPalang Chotsiri, Almahamoudou Mahamar, Halimatou Diawara, et al.
British Journal of Clinical Pharmacology|September 29, 2011
Artesunate/dihydroartemisinin pharmacokinetics in acute falciparum malaria in pregnancy: absorption, bioavailability, disposition and disease effectsRose McGready, Aung Pyae Phyo, Marcus J Rijken, et al.
Antiviral Therapy|December 25, 2012
Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokineticsSachiko Seo, Janet A Englund, Jack T Nguyen, et al.
AIDS Research and Human Retroviruses|November 21, 2013
Transient increase of interferon-stimulated genes and no clinical benefit by chloroquine treatment during acute simian immunodeficiency virus infection of macaquesMonica Vaccari, Claudio Fenizia, Zhong-Min Ma, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 9, 2026
Repurposing Oxfendazole for Onchocerciasis: Population Pharmacokinetics of a Tablet Formulation in Healthy African AdultsFrauke Assmus, Ayorinde Adehin, Richard M Hoglund, et al.
Malaria Journal|May 1, 2012
Pharmacokinetics and pharmacodynamics of intravenous artesunate during severe malaria treatment in Ugandan adultsPauline Byakika-Kibwika, Mohammed Lamorde, Jonathan Mayito, et al.
Antimicrobial Agents and Chemotherapy|May 28, 2015
Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical AssessmentRithea Leang, Walter R J Taylor, Denis Mey Bouth, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2019
Sequential Open-Label Study of the Safety, Tolerability, and Pharmacokinetic Interactions between Dihydroartemisinin-Piperaquine and Mefloquine in Healthy Thai AdultsBorimas Hanboonkunupakarn, Rob W van der Pluijm, Richard Hoglund, et al.
BMJ Global Health|April 22, 2024
Comparison of WHO versus national COVID-19 therapeutic guidelines across the world: not exactly a perfect matchMia Cokljat, Cintia Valeria Cruz, Verena Ilona Carrara, et al.
Pageof 25

Showing results (141-150 of 248) with videos related to

Sort By:
Pageof 25
Antimicrobial Agents and Chemotherapy|October 1, 2014
Open-label crossover study of primaquine and dihydroartemisinin-piperaquine pharmacokinetics in healthy adult thai subjectsBorimas Hanboonkunupakarn, Elizabeth A Ashley, Podjanee Jittamala, et al.
Malaria Journal|May 21, 2024
Population pharmacokinetics of primaquine and its metabolites in African malesPalang Chotsiri, Almahamoudou Mahamar, Halimatou Diawara, et al.
British Journal of Clinical Pharmacology|September 29, 2011
Artesunate/dihydroartemisinin pharmacokinetics in acute falciparum malaria in pregnancy: absorption, bioavailability, disposition and disease effectsRose McGready, Aung Pyae Phyo, Marcus J Rijken, et al.
Antiviral Therapy|December 25, 2012
Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokineticsSachiko Seo, Janet A Englund, Jack T Nguyen, et al.
AIDS Research and Human Retroviruses|November 21, 2013
Transient increase of interferon-stimulated genes and no clinical benefit by chloroquine treatment during acute simian immunodeficiency virus infection of macaquesMonica Vaccari, Claudio Fenizia, Zhong-Min Ma, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 9, 2026
Repurposing Oxfendazole for Onchocerciasis: Population Pharmacokinetics of a Tablet Formulation in Healthy African AdultsFrauke Assmus, Ayorinde Adehin, Richard M Hoglund, et al.
Malaria Journal|May 1, 2012
Pharmacokinetics and pharmacodynamics of intravenous artesunate during severe malaria treatment in Ugandan adultsPauline Byakika-Kibwika, Mohammed Lamorde, Jonathan Mayito, et al.
Antimicrobial Agents and Chemotherapy|May 28, 2015
Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical AssessmentRithea Leang, Walter R J Taylor, Denis Mey Bouth, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2019
Sequential Open-Label Study of the Safety, Tolerability, and Pharmacokinetic Interactions between Dihydroartemisinin-Piperaquine and Mefloquine in Healthy Thai AdultsBorimas Hanboonkunupakarn, Rob W van der Pluijm, Richard Hoglund, et al.
BMJ Global Health|April 22, 2024
Comparison of WHO versus national COVID-19 therapeutic guidelines across the world: not exactly a perfect matchMia Cokljat, Cintia Valeria Cruz, Verena Ilona Carrara, et al.
Pageof 25